The store will not work correctly when cookies are disabled.
1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-4-phenyl-1H-1,2,3-triazole
ID: ALA397814
PubChem CID: 11653357
Max Phase: Preclinical
Molecular Formula: C15H8Cl2F3N3
Molecular Weight: 358.15
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: FC(F)(F)c1cc(Cl)c(-n2cc(-c3ccccc3)nn2)c(Cl)c1
Standard InChI: InChI=1S/C15H8Cl2F3N3/c16-11-6-10(15(18,19)20)7-12(17)14(11)23-8-13(21-22-23)9-4-2-1-3-5-9/h1-8H
Standard InChI Key: BIFRWXWQOHESSZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
14.6900 -5.1360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4752 -4.8823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4784 -4.0572 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.6918 -3.7998 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.2086 -4.4674 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.3835 -4.4664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9754 -3.7516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1511 -3.7503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7369 -4.4648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1530 -5.1822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9759 -5.1801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9119 -4.4649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0798 -4.5017 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.8936 -3.6401 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.9383 -5.2896 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
13.3910 -5.8930 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
13.3902 -3.0384 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
16.1412 -5.3692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0474 -6.1878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7128 -6.6745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4684 -6.3410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5547 -5.5163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8885 -5.0333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11 6 1 0
1 2 2 0
9 12 1 0
5 6 1 0
12 13 1 0
12 14 1 0
6 7 2 0
12 15 1 0
2 3 1 0
11 16 1 0
7 8 1 0
7 17 1 0
3 4 2 0
2 18 1 0
8 9 2 0
18 19 2 0
4 5 1 0
19 20 1 0
9 10 1 0
20 21 2 0
5 1 1 0
21 22 1 0
10 11 2 0
22 23 2 0
23 18 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 358.15 | Molecular Weight (Monoisotopic): 357.0047 | AlogP: 5.26 | #Rotatable Bonds: 2 |
Polar Surface Area: 30.71 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 5.80 | CX LogD: 5.80 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.63 | Np Likeness Score: -1.56 |
References
1. Alam MS, Huang J, Ozoe F, Matsumura F, Ozoe Y.. (2007) Synthesis, 3D-QSAR, and docking studies of 1-phenyl-1H-1,2,3-triazoles as selective antagonists for beta3 over alpha1beta2gamma2 GABA receptors., 15 (15): [PMID:17544280] [10.1016/j.bmc.2007.05.039] |